Endoscopic ablation is a cost-effective cancer preventative therapy in patients with Barrett’s esophagus who have elevated genomic instability

Background: The surveillance of patients with nondysplastic Barrett’s esophagus (NDBE) has a high cost and is of limited effectiveness in preventing esophageal adenocarcinoma (EAC). Ablation for NDBE remains expensive and controversial. Biomarkers of genomic instability have shown promise in identif...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, Ananya, Callenberg, Keith M., Styn, Mindi A., Jackson, Sara A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: © Georg Thieme Verlag KG 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874803/
https://www.ncbi.nlm.nih.gov/pubmed/27227114
http://dx.doi.org/10.1055/s-0042-103415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874803/
https://www.ncbi.nlm.nih.gov/pubmed/27227114
http://dx.doi.org/10.1055/s-0042-103415

Ejemplares similares